Upgrade to SI Premium - Free Trial

Juno Therapeutics (JUNO) JCAR015 Phase II ROCKET Trial Placed on Clinical Hold

November 23, 2016 8:01 AM
Juno Therapeutics, Inc. (Nasdaq: JUNO) announced that it has voluntarily placed on hold the Phase II clinical trial of JCAR015 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News Trader Talk

Next Articles